International Assets Investment Management’s AstraZeneca AZN Stock Holding History

International Assets Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318K	Buy	1,729 +406	+31%	+$76.4K	0.02%	664
2026 Q1	$266K	Sell	1,323 -13	-1%	-$2.51K	0.02%	675
2025 Q4	$246K	Sell	1,336 -372	-22%	-$65.2K	0.02%	730
2025 Q3	$244K	Hold	1,708	–	–	0.02%	681
2025 Q2	$239K	Buy	+1,708	New	+$239K	0.02%	692
2025 Q1	–	Sell	-2,553	Closed	-$336K	–	772
2024 Q4	$336K	Buy	2,553 +732	+40%	+$102K	0.03%	532
2024 Q3	$284K	Sell	1,821 -88	-5%	-$14.2K	0.02%	485
2024 Q2	$298K	Buy	+1,909	New	+$287K	0.03%	547
2023 Q3	–	Sell	-1,542	Closed	-$221K	–	628
2023 Q2	$221K	Sell	1,542 -447	-22%	-$65.8K	0.03%	480
2023 Q1	$276K	Sell	1,989 -528	-21%	-$71K	0.04%	386
2022 Q4	$341K	Buy	+2,517	New	+$316K	0.04%	431
2021 Q2	–	Sell	-1,527	Closed	-$153K	–	617
2021 Q1	$153K	Hold	1,527	–	–	0.01%	581
2020 Q4	$153K	Buy	+1,527	New	+$162K	0.03%	458

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

International Assets Investment Management's AZN Position: Q2 2026 in Review

International Assets Investment Management increased its AstraZeneca (AZN) stake by 31% in Q2 2026, buying an estimated $76.4K and bringing the position to 1,729 shares worth $318K. The position accounts for 0.02% of the portfolio, ranked #664.

International Assets Investment Management first reported a position in AZN in Q4 2020 and has held it in 13 quarters since. The position peaked at $341K in Q4 2022. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

International Assets Investment Management held 1,729 shares of AstraZeneca worth $318K as of Q2 2026.
International Assets Investment Management bought 406 AstraZeneca shares in Q2 2026, an estimated $76.4K.
AstraZeneca made up 0.02% of International Assets Investment Management's portfolio in Q2 2026, its #664 holding.
International Assets Investment Management first reported a position in AstraZeneca in Q4 2020 and has held it in 13 quarters since.
International Assets Investment Management's AstraZeneca position peaked at $341K in Q4 2022.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.